Codexis grants director options on 66,350 shares
CODEXIS, INC. director Cynthia Collins received a grant of stock options covering 66,350 shares of common stock at an exercise price of $2.48 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CODEXIS, INC. director Cynthia Collins received a grant of stock options covering 66,350 shares of common stock at an exercise price of $2.48 per share. The options vest in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, and expire in 2036.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 66,350 | $0.00 | $0.00 |
Footnotes (1)
- F1. This option vests and becomes exercisable with respect to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
exercise price financial
vesting financial
annual stockholder meeting financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Codexis (CDXS) director Cynthia Collins receive in this Form 4 filing?
What is the exercise price of Cynthia Collins’ new Codexis (CDXS) stock options?
When do Cynthia Collins’ Codexis (CDXS) stock options vest according to the Form 4?
How many Codexis (CDXS) options does Cynthia Collins hold after this transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.